Unique clinical trials and novel products of interest currently under investigation for the treatment of dry eye disease.
Intracameral tPA can treat fibrinous clots in severe anterior uveitis.
Representatives from Magellan Rx Management provided a detailed overview of current treatment options in ophthalmology and the impact that biosimilars could have.
Virtual reality and artificial intelligence are reshaping medical education.
Physicians can use navigational tools to attain a much more immersive perspective.
Sunil Srivastava, MD, shares his experience using dexamethasone and fluocinolone acetonide implants to manage chronic non-infectious uveitis.
Lens thickness and anterior chamber duct values obtained by Lenstar can be improved by SpikeFinder to reduce errors in measurements.
Papilledema with back pain suggests spine lesion.
Having a comprehensive team of ophthalmic specialists in place means patients could have multiple issues treated in a single procedure that might require two surgeries otherwise.
Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.
Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.
Hidden signs of systemic disease, including heart attacks, may first reveal themselves through visual symptoms or subtle patient cues in the exam chair.
As dexamethasone adds indications, a study confirms efficacy of punctal occlusion for allergic conjunctivitis.
From cytokine pathways to genomics, Shree Kurup, MD, highlights new approaches for managing diabetic retinopathy and combating systemic inflammation.
When it comes to the sexes in the operating room, the key is collaboration, with a goal of presenting patient suffering.
Understand the anatomical risks, technique-specific benefits, and patient selection criteria
Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease
Higher levels of 3 macular pigments minimize risk of age-related disease.
Deep learning discerns IIH, NAION, and normal eyes using single fundus image.
At ARVO 2025, in Salt Lake City, Utah, Steven Barnes, PhD, talked about his research on the OPA1 mutation in retinal ganglion cells' effect on the cell's electrical function.
Andrew Iwach, MD, co-founder of the Glaucoma 360 meeting shares that value this meeting has for residents and fellows as they embark on their careers and the future additions to the meeting that will include retina discussions.
Drops can simplify dosing, improving adherence and ocular surface health
Nicole Fram, MD concludes this series on the potential of decentration and subsequent IOLs misalignment, highlighting zero and negative spherical aberration lens options for these unique cases.